Genesco Files Routine 8-K, Confirms Non-Emerging Growth Status
Ticker: GCO · Form: 8-K · Filed: Jan 8, 2024 · CIK: 18498
Complexity: simple
Sentiment: neutral
Topics: regulatory-filing, corporate-governance
TL;DR
**Genesco's 8-K is a routine administrative filing with no new material news.**
AI Summary
Genesco Inc. filed an 8-K on January 8, 2024, primarily to disclose general corporate information and confirm its status as a non-emerging growth company. This filing, under Regulation FD Disclosure and Financial Statements and Exhibits, doesn't contain specific financial figures or major operational changes. For investors, this filing is largely administrative and doesn't signal any immediate shifts in the company's financial health or strategic direction, meaning there's no new information to significantly impact stock valuation based on this document alone.
Why It Matters
This filing is a standard administrative update, confirming Genesco's compliance with SEC regulations but offering no new material information that would typically move the stock.
Risk Assessment
Risk Level: low — This 8-K is a procedural filing and does not introduce any new financial or operational risks to the company.
Analyst Insight
Smart investors would note this as a routine compliance filing and understand it contains no new material information to warrant any immediate investment action or change in their thesis on GCO.
Key Players & Entities
- Genesco Inc. (company) — the registrant filing the 8-K
- New York Stock Exchange (company) — where Genesco's Common Stock is registered
- GCO (company) — Genesco's trading symbol
- January 08, 2024 (date) — date of earliest event reported
- $1.00 (dollar_amount) — par value of Common Stock
FAQ
What is the purpose of Genesco Inc.'s 8-K filing dated January 8, 2024?
The 8-K filing by Genesco Inc. on January 8, 2024, serves as a Current Report under Section 13 or 15(d) of the Securities Exchange Act of 1934, primarily for Regulation FD Disclosure and Financial Statements and Exhibits. It's a routine administrative filing.
What is Genesco Inc.'s trading symbol and on which exchange is its common stock registered?
Genesco Inc.'s trading symbol is GCO, and its Common Stock, with a $1.00 par value, is registered on the New York Stock Exchange.
What is the earliest event reported date in this 8-K filing?
The Date of Report (Date of earliest event reported) for this 8-K filing is January 08, 2024.
Is Genesco Inc. classified as an 'emerging growth company' according to this filing?
No, the filing indicates with an unchecked box that Genesco Inc. is not an 'emerging growth company' as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
What is Genesco Inc.'s business address and phone number as stated in the filing?
Genesco Inc.'s business address is 535 Marriott Drive, Nashville, Tennessee, 37214, and its telephone number is 615 367-7000.
Filing Stats: 482 words · 2 min read · ~2 pages · Grade level 10.5 · Accepted 2024-01-08 08:08:35
Key Financial Figures
- $1.00 — nge on which registered Common Stock, $1.00 par value GCO New York Stock Exchan
Filing Documents
- gco-20240108.htm (8-K) — 39KB
- gco-ex99_1.htm (EX-99.1) — 61KB
- 0000950170-24-002712.txt ( ) — 215KB
- gco-20240108.xsd (EX-101.SCH) — 23KB
- gco-20240108_htm.xml (XML) — 4KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On January 8, 2024, Genesco Inc. issued a press release announcing comparable sales by retail segment and for the entire Company for the fourth fiscal quarter-to-date period ended December 30, 2023 and revising its earnings guidance for the fiscal year. The Company previously announced that management will make a presentation at the 2024 ICR Conference at 9:30am (Eastern time) on Monday, January 8, 2024. The audio portion of the presentation will be webcast live and may be accessed through the Company's internet website, http://www.genesco.com. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press Release of Genesco Inc. dated January 8, 2024 104 Cover Page Interactive Data File (formatted as inline XBRL)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GENESCO INC. Date: January 8, 2024 By: /s/ Scott E. Becker Scott E. Becker Senior Vice President, Corporate Secretary and Genearl Counsel